BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo

INDGN vs TAKE: Stock Comparison

INDEGENE vs TAKEUpdated 20 Nov 26, 4:08 PM ISTNSE & company filings

INDEGENE is the larger company by market capitalisation. INDEGENE shows a higher dividend yield, faster revenue growth and a higher net margin, while TAKE shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDGN leads 7; TAKE leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDGNTAKE

Valuation lens

What price are you paying?

Market CapContext only
₹15,807 Cr
₹203 Cr
P/E RatioTAKE has the lower reading
38.43x
26.86x ✓
P/B RatioINDGN has the lower reading
4.71x ✓
11.13x
EPSINDGN has the higher reading
₹4.66 ✓
₹0.15
Book ValueContext only
₹130.25
₹2.1
Dividend YieldINDGN has the higher reading
0.34% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
INDGN is the larger company
₹15,807 Cr vs ₹203 Cr
P/E Ratio
TAKE has a lower P/E
26.86x vs 38.43x
P/B Ratio
INDGN has a lower P/B
4.71x vs 11.13x
EPS
INDGN has higher earnings per share
₹4.66 vs ₹0.15
Dividend Yield
INDGN has a higher dividend yield
0.34% vs 0%
Revenue Growth (TTM YoY)
INDGN has faster revenue growth
32.8% vs 0%
EPS Growth (TTM YoY)
TAKE has faster EPS growth
0% vs -32.3%
Qtr Sales Growth
INDGN has stronger quarterly sales growth
5.57% vs -3.15%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDGNTAKE
SectorHealthcare—
IndustryHealthcare Research Analytics & Technology—

Price

MetricINDGNTAKE
Live Price₹657.65₹13.69
Day Change1.9%4.98%
Volume3.21 L7.57 L
52-Week High₹677₹24.39
52-Week Low₹414₹9.88
Distance from 52W High-2.86%-43.87%

Valuation

MetricINDGNTAKE
Market Cap₹15,807 Cr₹203 Cr
P/E Ratio38.43x26.86x
P/B Ratio4.71x11.13x
EPS₹4.66₹0.15
Book Value₹130.25₹2.1
Dividend Yield0.34%0%

Growth

MetricINDGNTAKE
Revenue Growth (TTM YoY)32.8%0%
EPS Growth (TTM YoY)-32.3%0%
Qtr Sales Growth5.57%-3.15%
Qtr Profit Growth-3.36%108.2%

Profitability & Leverage

MetricINDGNTAKE
ROE10.19%12.68%
ROCE10.75%14.44%
Net Margin12.03%0%
Operating Margin23.77%8.19%
Debt to Equity0x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricINDGNTAKE
Promoter Holding—0%
FII Holding12.4%▲ 2.49 pp0.21%
DII Holding15.82%▲ 7.08 pp0%
Public Holding71.77%▼ 9.57 pp99.79%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDEGENE and TAKE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.